Vitiligo and Epigenetics: From Pathogenesis to Clinical Applications
Experimental Dermatology · 2025
DOI: 10.1111/exd.70178 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Experimental Dermatology, 2025. Verfasst von Huimin He und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Chin…. Hauptthemen laut MEDLINE: Vitiligo, Epigenesis, Genetic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: National High Level Hospital Clinical Research Funding, Beijing Municipal Natural Science Foundation, Beijing Key Clinical Specialty Construction Project.
Abstract (Originalsprache)
Vitiligo is a multifactorial chronic depigmentary disorder characterised by the loss of functional melanocytes. Its pathogenesis involves complex interactions among genetic predisposition, environmental factors, and autoimmune dysregulation. In recent years, extensive research has highlighted the critical role of epigenetic regulation in vitiligo development, including aberrant DNA methylation, dysregulated histone modifications, and non‐coding RNA (ncRNA) expression disturbances. These abnormal epigenetic modifications contribute to disease progression by disrupting melanogenesis, promoting oxidative stress–induced melanocyte apoptosis, and driving autoimmune responses. From a translational perspective, specific epigenetic alterations show potential as diagnostic biomarkers, disease severity indicators, and therapeutic response monitors. Furthermore, epigenetic drugs, CRISPR/dCas9‐based epigenetic editing, and targeted epigenetic reprogramming of tissue‐resident memory T cells demonstrate promising clinical applications. This review systematically summarises the molecular mechanisms underlying epigenetic dysregulation in vitiligo pathogenesis and explores its translational implications, providing a theoretical foundation for advancing disease understanding and developing novel therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China.
- National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China.
ORCID-Profile: Tao Wang
Förderung
- National High Level Hospital Clinical Research Funding
- Beijing Municipal Natural Science Foundation
- Beijing Key Clinical Specialty Construction Project
- National Key Clinical Specialty Project of China
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
He, H., & Wang, T. (2025). Vitiligo and Epigenetics: From Pathogenesis to Clinical Applications. Experimental Dermatology. https://doi.org/10.1111/exd.70178
Vancouver
He H, Wang T. Vitiligo and Epigenetics: From Pathogenesis to Clinical Applications. Experimental Dermatology. 2025. doi:10.1111/exd.70178
BibTeX
@article{He2025,
author = {He, Huimin and Wang, Tao},
title = {Vitiligo and Epigenetics: From Pathogenesis to Clinical Applications},
journal = {Experimental Dermatology},
year = {2025},
doi = {10.1111/exd.70178}
}
EUVIMED